You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A GREEN AND UNIQUE THERMOSETTING-THERMOPLASTIC POLYCARBONATE
SBC: INSTRUMENTAL POLYMER TECHNOLOGIES, LLC Topic: 16NCER2BOf the 300 million tons of plastic produced per year most will require 500 years to biodegrade. Currently only 9% is recycled, and 50 million tons of thermoset plastic produced annually that can't be recycled. _x000D_ _x000D_ This project will develop a sustainable and easily biodegradable polycarbonate plastic that is uniquely a recyclable thermoset resin. We call it a thermosetting thermoplastic ...
SBIR Phase II 2018 Environmental Protection Agency -
Development of Innovative Broad-Spectrum Analysis Methods for PFAS
SBC: SEACOAST SCIENCE, INC. Topic: 17NCER3AThis SBIR addresses EPA’s need for improved sampling and analysis technologies to detect Per- and Polyfluoroalkyl Substances (PFAS). PFAS are used in firefighting sprays, at airports, and for wild fires, and have been used in textile treatments (e.g., it is a component in Scotchgard). It is estimated that 65 million Americans are at risk of PFAS exposure in their drinking water. Seacoast propose ...
SBIR Phase I 2018 Environmental Protection Agency -
Greener Plastics with High Heat Tolerance for Additive Manufacturing
SBC: INTELLIGENT OPTICAL SYSTEMS, INC. Topic: 17NCER5BAdvances in materials and automation are rapidly reshaping the American manufacturing economy. These advances must be embraced to sustain a strong manufacturing sector in the United States. Additive manufacturing is possibly the fastest growing example of this trend, growing at an astonishing compound annual growth rate of 25.7%. The plastic materials market for additive manufacturing, valued at $ ...
SBIR Phase I 2018 Environmental Protection Agency -
Renewable Bioplastics Production
SBC: ALTEX TECHNOLOGIES CORPORATION Topic: 17NCER5AAltex’s Renewable Bioplastics Production (RBP) technology meets the Greener Plastic Manufacturing needs; to eliminate harmful-petrochemical feed sources, to accomplish toxic-free, low-energy, low cost bioplastics production, to reduce Green House Gas (GHG) emissions, and to have environment friendly-biodegradable bioplastics. Altex’s proposed RBP technology combines a novel feeding-sizing-pret ...
SBIR Phase I 2018 Environmental Protection Agency -
Prehospital and Emergency Room Stroke Diagnosis Using Quantitative Cerebral Hemodynamics
SBC: Neural Analytics, Inc. Topic: NINDSLarge vessel acute ischemic strokeAISis the leading cause of disability and fourth leading cause of death with approximatelyper year in the United States aloneAlthough treatments including interventionalstentrieverand pharmaceuticaltPAexist for large vessel occlusionLVOthere is not a rapid prehospital tool for diagnoses which guides the use of the correct therapyBecause the time to treatment for s ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Clothing-Adhered Wearable to Monitor Biomarkers of Cognitive/Emotional State and Deliver Just-in-Time Behavioral Interventions
SBC: Spire, Inc. Topic: NIDAPROJECT SUMMARY Recovery from substance use disorders (SUDs) is greatly impacted by the cognitive and emotional state of the individual, and learning new thought and behavioral patterns can facilitate successful treatment and recovery. Specifically, fluctuations in stress or anxiety can trigger lapses to drug use. Even when actual use is avoided, stress-induced craving is likely to be distracting ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Novel Therapeutic that Harnesses MIcrotubules to Enhance Corneal Wound Healing Following an Alkaline Burn
SBC: MICROCURES INC Topic: NEIThe cornea is one of the most important tissues in the eye and its transparency is critical for good visual function in humansCorneal tissue injuries are the most common everyday issue for practicing ophthalmologists and can run the gamut in severityIn severe modelssuch as corneal alkaline burnsextensive healing is needed and often the burn victim is left with reduced visual acuityHealing of large ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement
SBC: Theranova LLC Topic: NIAAbstract Improper placement of peripherally inserted central cathetersPICCsis costly and has serious complications for critically ill patientsMore than one million PICCs are placed each year to provide IV therapieswhere navigation through the venous system is typically performed blindor without navigation guidanceAs a resultof PICC tips are not optimally placed on the first attempt and require rep ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Preclinical Development of Oxy200 for the Treatment of Osteoporosis
SBC: Max Biopharma, Inc. Topic: NIAABSTRACT Osteoporosis directly affectsmillion Americans and anothermillion are osteopenic and at risk for developing osteoporosisPostmenopausal osteoporosis is most commonbut osteoporosis does also frequently affect older menAt MAX BioPharmawe are developing new and improved therapies for osteoporosis that aim to rebalance both bone formation and resorption based on a dual therapy approachBisphosp ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease
SBC: NEWOMICS INC. Topic: NIAProject Summary Abstract Alzheimerandapos s diseaseADis a devastating neurodegenerative disease that affects more thanmillion peopleincludingmillion Americansworldwideand this number is expected to reach more thanmillion by the yearRecent disappointing results from a large number of clinical trials for AD treatment further aggravate the problemOne major challenge is there is currently no blood bas ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health